Market Overview

Navidea Biopharma Awarded Fast-Track SBIR Grant Funds Of Potentially $1.8M To Be Released in 3 Parts Over 2.5 Years With Goal Of Completing IND Submission For Manocept Construct

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News FDA

 

Related Articles (NAVB)